Home Cart Sign in  
Chemical Structure| 716354-86-8 Chemical Structure| 716354-86-8

Structure of CCR5 antagonist 1
CAS No.: 716354-86-8

Chemical Structure| 716354-86-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CCR5 antagonist 1 is a CCR5 antagonist which can inhibit HIV replication extracted from WO 2004054974 A2.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CCR5 antagonist 1

CAS No. :716354-86-8
Formula : C39H46ClF2N5O3S
M.W : 738.33
SMILES Code : O=S(C1=CC(C(N2CCC(CCN3[C@H]4C[C@H](N5C6=CC=CC=C6N=C5C)C[C@@H]3CC4)(C7=CC=CC(F)=C7)CC2)=O)=C(Cl)C=C1F)(NC(C)(C)C)=O
MDL No. :MFCD30747837

Safety of CCR5 antagonist 1

Related Pathways of CCR5 antagonist 1

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00428519 HIV Infections Phase 1 Completed - United States, Pennsylvania ... More >> Clinical Trials Unit. University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02302547 HIV Phase 3 Completed - France ... More >> Unité des Maladies Infectieuses, CHU de CAEN Caen, France, 14033 Service des Maladies Infectieuses, CHR Orléans La Source, ORLEANS CEDEX 2 CHR d'ORLEANS, France, 45067 Service d'Immunologie Clinique centre de Vaccination anti- VIH ANRS Hopital Henri- Mondor Creteil, France, 94010 Service de Médecine Interne et Maladies Infectieuses, Groupe Hospitalier La Rochelle, Cedex 01 La Rochelle, France, 17019 Service de Pneumologie, centre Hospitalier Fontenoy, CH de CHARTRES Le Coudray, France, 28630 CHU de NANCY Nancy, France, 54035 Service des maladies Infectieuses et tropicales, CH GEORGES RENON Niort, France, 79021 Service des Maladies Infectieuses et tropicales, APHP SAINT LOUIS Paris, France, 75475 Hospital Tenon Paris, France, 75970 Centre de diagnostic et thérapeutique, Hopital Hotel Dieu Paris, France, 94010 Consultation Maladies Infectieuses, Chu de Poitiers, Cedex Poitiers, France, 86021 Maladies Infectieuses, CHU de ROUEN Rouen, France, 76031 Service de Médecine Interne, CH de SAINTONGE- BP 326 Saintes, France, 17108 Médecine Interne, Hôpital FOCH Suresnes, France, 92151 Service Universitaire des Maladies Infectieuses et du Voyageur, CH DRON Tourcoing, France, 59200 Service de Medecine Interne et Maladies Infectieuses, CHRU BRETONNEAU, TOURS CEDEX9 Tours, France, 37044 Less <<
NCT01300988 HIV Infection Phase 1 Completed - United States, Pennsylvania ... More >> Clinical Trials Unit. University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104--607 Less <<
NCT01348308 HIV-1 Infection ... More >> AIDS Less << Phase 3 Completed - France ... More >> Hôpital Henri Mondor Creteil, France, 94010 Less <<
NCT00709111 HIV Infections Not Applicable Completed - -
NCT01749566 HIV Phase 1 Completed - United States, Georgia ... More >> Grady Infectious Diseases Program Atlanta, Georgia, United States, 30303 Less <<
NCT00709111 - Completed - -
NCT03767582 Locally Advanced Pancreatic Du... More >>ctal Adenocarcinoma (PDAC) Pancreatic Ductal Adenocarcinoma Less << Phase 1 Phase 2 Not yet recruiting January 2022 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center Not yet recruiting Baltimore, Maryland, United States, 21231 Contact: Susan Sartorius-Mergenthaler, RN    410-614-3644    Sartosu@jhmi.edu    Contact: Jane Zorzi, RN    410-614-5818    Jzorzi1@jhmi.edu Less <<
NCT02990312 Hiv Kidney Tr... More >>ansplant HIV Reservoir CCR5 Less << Phase 4 Recruiting July 2020 United States, Maryland ... More >> Institute of human virology Recruiting Baltimore, Maryland, United States, 21201 Contact: Jennifer Husson, MD    410-706-6973    Jhusson@ihv.umaryland.edu    Contact: Ilise Marrazzo    4107062564    IMarrazzo@ihv.umaryland.edu Less <<
NCT01076179 - Completed - -
NCT00076284 HIV Infections Phase 2 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT01076179 - Completed - -
NCT02355184 HIV Human Imm... More >>unodeficiency Virus Less << Phase 2 Active, not recruiting September 2018 United States, California ... More >> Quest Clinical Research San Francisco, California, United States, 94115 Less <<
NCT00795444 HIV-1 Phase 2 Completed - Spain ... More >> Hospital Universitario Ramon Y Cajal Madrid, Spain, 28034 Less <<
NCT00703586 HIV Infections Phase 1 Completed - United States, New York ... More >> Rockefeller University Hospital New York, New York, United States, 10065 Less <<
NCT00197197 HIV Infection Phase 3 Terminated(The study was termi... More >>nated due to hepatoxicity of compound) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90046 United States, Connecticut GSK Investigational Site Norwalk, Connecticut, United States, 06851 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33308 GSK Investigational Site Hollywood, Florida, United States, 33020 GSK Investigational Site Plantation, Florida, United States, 33317 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30339 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60657 United States, Louisiana GSK Investigational Site New Orleans, Louisiana, United States, 70127-0800 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21201 United States, New Jersey GSK Investigational Site Newark, New Jersey, United States, 07102 United States, Texas GSK Investigational Site Houston, Texas, United States, 77027 Belgium GSK Investigational Site Bruxelles, Belgium, 1000 Less <<
NCT00393120 HIV Infections Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States, 90069 United States, District of Columbia Washington, District of Columbia, United States, 20007 United States, Florida Orlando, Florida, United States, 32803 Vero Beach, Florida, United States, 32960 United States, Massachusetts Boston, Massachusetts, United States, 02130 United States, Virginia Annandale, Virginia, United States, 20037 Less <<
NCT00297076 HIV Infection Phase 3 Terminated October 2007 Germany ... More >> GSK Investigational Site Frankfurt, Hessen, Germany, 60590 GSK Investigational Site Hannover, Niedersachsen, Germany, 30159 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Duesseldorf, Nordrhein-Westfalen, Germany, 40225 GSK Investigational Site Berlin, Germany, 13353 Less <<
NCT02486510 HIV-1 Infection Early Phase 1 Terminated(Futility criteria) - Spain ... More >> Hospital Universitario Ramon Y Cajal Madrid, Spain, 28034 Hospital Universitario La Paz Madrid, Spain, 28046 Less <<
NCT00766597 - Completed - -
NCT00766597 HIV Infections Phase 1 Phase 2 Completed - United States, California ... More >> UCSD Mother-Child-Adolescent Program CRS San Diego, California, United States United States, District of Columbia Children's National Med. Ctr. Washington DC NICHD CRS Washington, District of Columbia, United States, 20010 Howard Univ. Washington DC NICHD CRS Washington, District of Columbia, United States, 20060 United States, Illinois Chicago Children's CRS Chicago, Illinois, United States, 60614 United States, New York Jacobi Med. Ctr. Bronx NICHD CRS Bronx, New York, United States, 10461 Bronx-Lebanon Hosp. IMPAACT CRS Bronx, New York, United States Metropolitan Hosp. NICHD CRS New York, New York, United States, 10029 United States, Tennessee St. Jude/UTHSC CRS Memphis, Tennessee, United States, 38105 Puerto Rico Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS San Juan, Puerto Rico, 00935 Less <<
NCT02483078 HIV Phase 2 Phase 3 Active, not recruiting August 2018 -
NCT00197145 Infection, Human Immunodeficie... More >>ncy Virus I Less << Phase 3 Terminated - -
NCT00123890 HIV Infection Phase 3 Terminated(The study was termi... More >>nated due to hepatoxicity of compound) Less << - -
NCT02175680 HIV Human Imm... More >>unodeficiency Virus Less << Phase 2 Completed - United States, California ... More >> Quest Clinical Research San Francisco, California, United States, 94115 Less <<
NCT00098722 HIV Infections Phase 2 Phase 3 Completed - -
NCT00098748 HIV Infections Phase 2 Phase 3 Completed - -
NCT00098722 - Completed - -
NCT00098293 HIV-1 Phase 3 Completed - -
NCT00098306 HIV Infections Phase 2 Phase 3 Completed - United States, California ... More >> Pfizer Investigational Site Sacramento, California, United States, 95825 Pfizer Investigational Site San Francisco, California, United States, 94115 Pfizer Investigational Site San Francisco, California, United States, 94118 Pfizer Investigational Site San Francisco, California, United States, 94121 United States, Colorado Pfizer Investigational Site Auroa, Colorado, United States, 80045 Pfizer Investigational Site Aurora, Colorado, United States, 80045 United States, District of Columbia Pfizer Investigational Site Washington, District of Columbia, United States, 20036 United States, Florida Pfizer Investigational Site Tampa, Florida, United States, 33602 Pfizer Investigational Site Tampa, Florida, United States, 33614 Pfizer Investigational Site Vero Beach, Florida, United States, 32960 United States, Georgia Pfizer Investigational Site Atlanta, Georgia, United States, 30308 United States, Louisiana Pfizer Investigational Site New Orleans, Louisiana, United States, 70112 United States, New Mexico Pfizer Investigational Site Santa Fe, New Mexico, United States, 87505 United States, New York Pfizer Investigational Site Bronx, New York, United States, 10467 Pfizer Investigational Site New York, New York, United States, 10003 Pfizer Investigational Site Rochester, New York, United States, 14642 United States, Ohio Pfizer Investigational Site Cincinnati, Ohio, United States, 45267-0405 United States, Oregon Pfizer Investigational Site Portland, Oregon, United States, 97219 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78705 United States, Virginia Pfizer Investigational Site Annandale, Virginia, United States, 22003 Canada, British Columbia Pfizer Investigational Site Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H2L 4P9 Less <<
NCT00808002 HIV Infections Phase 3 Completed - Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital Clinic i Provincial de Barcelona Barcelona, Spain, 08916 Less <<
NCT01060618 HIV Infections Phase 2 Phase 3 Completed - Spain ... More >> Hospital General Universitario Gregorio Marañón Madrid, Spain, 280007 Hospital Ramón y Cajal Madrid, Spain, 28034 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Less <<
NCT00098293 - Completed - -
NCT01092104 HIV-1 Infection Phase 1 Phase 2 Completed - -
NCT01378910 HIV Phase 4 Completed - Spain ... More >> Hospital Xeral de Vigo Santiago de Compostela, A Coruña, Spain, 15781 Hospital de Elche Elche, Alicante, Spain, 03203 Hospital Son Espases Palma de Mallorca, Baleares, Spain, 07011 H. U. Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 H. de Bellvitge Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital U. Marqués de Valdecilla Santander, Cantabria, Spain, 39011 Hospital Sta. Lucía/ H. Sta. Mª del Rosell Cartagena, Murcia, Spain, 30203 Hospital General de Castellón Castellón, Valencia, Spain, 12004 Hospital de Cruces Bilbao, Vizcaya, Spain, 48903 Hospital Gral. U. de Alicante Alicante, Spain, 03010 Hospital Vall d'Hebron Barcelona, Spain, 08035 Hospital de Mataró Barcelona, Spain, 08304 Hospital Virgen de las Nieves Granada, Spain, 18014 Hospital U. San Cecilio Granada, Spain, 28012 Hospital U. Gregorio Marañón Madrid, Spain, 28007 Hospital Carlos III Madrid, Spain, 28029 Hospital Ramón y Cajal Madrid, Spain, 28034 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Reina Sofía de Murcia Murcia, Spain, 30003 Hospital Sant Pau i Santa Tecla Tarragona, Spain, 43007 Hospital La Fe Valencia, Spain, 46009 Hospital Gral. U. de Valencia Valencia, Spain, 46014 Hospital Arnau de Vilanova Valencia, Spain, 46015 Hospital U. Dr. Peset Valencia, Spain, 46017 Less <<
NCT00098306 - Completed - -
NCT00197145 - Terminated - -
NCT00098748 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.35mL

0.27mL

0.14mL

6.77mL

1.35mL

0.68mL

13.54mL

2.71mL

1.35mL

 

Historical Records

Categories